Lipid nanoparticles have attracted significant interests in the last two decades, and have
achieved tremendous clinical success since the first clinical approval of Doxil in 1995. At the …

Every year, cancer is responsible for millions of deaths worldwide and, even though much
progress has been achieved in medicine, there are still many issues that must be addressed …

Many therapeutically active molecules are non-soluble in aqueous systems, chemically and
biologically fragile or present severe side effects. Lipid-based nanoparticle (LBNP) systems …

Drug delivery systems have opened new avenues to improve the therapeutic effects of
already-efficient molecules. Particularly, Solid Lipid Nanoparticles (SLNs) have emerged as …

Hepatocellular carcinoma (HCC) is the most common type of liver cancer and one of the
leading causes of cancer-related death worldwide. Advanced HCC displays strong …

Cancer accounts for millions of deaths every year and, due to the increase and aging of the
world population, the number of new diagnosed cases is continuously rising. Although many …

Liver cancer is considered one of the deadliest diseases with one of the highest disease
burdens worldwide. Among the different types of liver cancer, hepatocellular carcinoma is …

The emergence of nanomedicine drugs as a result of the fast advancement of
nanotechnology offers enormous potential for improving cancer treatment strategies. The …

Triple-negative breast cancer is considered the most aggressive type of breast cancer
among women and the lack of expressed receptors has made treatment options …

Recent advancements in drug delivery technologies paved a way for improving cancer
therapeutics. Nanotechnology emerged as a potential tool in the field of drug delivery …